Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified
Risks
- No material direct effect identified
FederalUS CongressUnknown
S. 2355: Patients Deserve Price Tags Act
Sen. Roger Marshall (R-KS)
S. 2355 status: Unknown.
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
79OUT OF 100
Score:79/100 civic fit
Risk:Low Risk
Impact:High Impact 85/100
Constitutionality95%
Bipartisan90%
Public opinion95%
Bill summary
What changes
The bill mandates comprehensive price transparency for hospitals, labs, imaging centers, and ambulatory surgical centers. It requires disclosure of gross charges, cash prices, and payer-specific negotiated rates in machine-readable formats. It also mandates that group health plans provide real-time self-service tools for price estimates and grants plan fiduciaries full access to claims data, effectively prohibiting 'gag clauses' in contracts.
Who is affected
Hospitals, laboratories, imaging providers, ambulatory surgical centers, health insurance issuers, and group health plan sponsors.
Requirements and enforcement
Entities must provide quarterly public updates of standard charges and ownership information, adhere to standard formatting, provide itemized bills, and submit to regular audits by the Secretaries of HHS and Labor.
Costs and funding
Requires new administrative systems for reporting and compliance monitoring; violators face daily civil monetary penalties.
When it takes effect
Provisions phase in between 2026 and 2027.
Potential benefits
Patients gain visibility into pricing to enable comparison shopping; plan sponsors gain the audit rights necessary to reduce healthcare spending.
Risks and tradeoffs
Compliance costs may be substantial, and the complexity of billing data may overwhelm average consumers.
What is still unknown
The effectiveness of these transparency requirements in actually lowering market prices remains an empirical question.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Positive outlook
75%
Benefits
- Increased price transparency potentially lowers costs through market competition
- Reduces information asymmetry between providers, payers, and patients
- Empowers employers/plan fiduciaries to audit and manage health plan expenditures
Risks
- Increased compliance costs for hospitals and providers updating systems
- Potential administrative burden on small clinics and laboratories
- Significant civil monetary penalties for non-compliance
Society
Positive outlook
80%
Benefits
- Improves patient ability to shop for healthcare services in advance
- Increases awareness of charity care policies and financial assistance
- Provides patients with itemized bills and clear price disclosures
Risks
- Risk of informational overload for patients despite consumer-friendly format requirements
- Dependency on digital literacy to effectively utilize price transparency tools
- Potential for temporary disruption in billing processes during transition periods
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified
Risks
- No material direct effect identified
Civic Accountability
Positive outlook
90%
Benefits
- Requires disclosure of ownership and control interests in hospitals and labs
- Mandates annual public reporting on enforcement actions by agencies
- Empowers plan fiduciaries with comprehensive claims and encounter data
Risks
- Heavy reliance on agency rulemaking to define technical standards
- Potential for regulatory capture if disclosure definitions are weak
- Enforcement depends on the Secretary’s sustained commitment to audits
Public Health & Safety
Positive outlook
70%
Benefits
- Greater transparency may lead to reduced medical debt for patients
- Standardizes the provision of good faith estimates for procedures
- Encourages integration of charity care policy awareness in patient billing
Risks
- Risk of diverting administrative resources away from clinical care
- Potential for provider exit from markets if compliance costs are prohibitive
- Concerns regarding the accuracy of estimate data for complex care paths
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Confidence
High
Information is complete and verified.
Analysis basis
Full bill text (Congress.gov)
Source used for this bill's analysis.
Warning
High compliance burden may disproportionately impact smaller, rural healthcare providers
Analysis scope
Implementation is heavily reliant on future agency rulemaking and guidance
04
Where it stands
Official recordStage unknown — no recognized legislative stage is recorded for this bill.
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.